Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Corbus Pharmaceuticals Holdings, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
Prev close 6.90 · gapped above the open, then crossed back over prior close. High/low 8.08 at 4:00 am ET, 6.42 at 11:30 am ET.
CRBP (Corbus Pharmaceuticals Holdings, Inc.) has 6 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Suppliers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
107 institutional managers report a position in Corbus Pharmaceuticals Holdings, Inc. worth $145.3M between them, filed on form 13F for the quarter ending 2026-06-30. 14 of them hold 80% of it, the largest being Cormorant Asset Management, LLC at 15.14%.
82 more managers in the register
14 managers hold 80% of the $145.3M institutional base. The other 93 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
via Orbimed Advisors LLC, Standard Life Aberdeen plc, Marshall Wace LLP · 11.22% of CRBP, 14.55% of NSPR
via Cormorant Asset Management, LLC, ADAR1 Capital Management, LLC, DAFNA Capital Management LLC · 15.14% of CRBP, 15.03% of ANL
via Orbimed Advisors LLC, Stonepine Capital Management, LLC, DAFNA Capital Management LLC +3 more · 11.22% of CRBP, 13.71% of ACET
via Cormorant Asset Management, LLC · 15.14% of CRBP, 30.23% of BBOT
via Orbimed Advisors LLC, Standard Life Aberdeen plc, ADAR1 Capital Management, LLC · 11.22% of CRBP, 9.11% of SPRY
via Orbimed Advisors LLC, ADAR1 Capital Management, LLC · 11.22% of CRBP, 19.54% of TRAW
Managers holding a meaningful stake in CRBP also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.